Molecular mechanism of mitochondrial mitoKATP channel openers in improving the cardiac oxidative stress/injury in rat models of coronary heart disease
Received:May 21, 2018  
View Full Text  View/Add Comment  Download reader
DOI:10.11915/j.issn.1671-5403.2019.02.026
Key words:coronary heart disease; cardiac oxidative stress/injury; mitochondrial ATP-sensitive potassium channels
Author NameAffiliationE-mail
SUN Zhao-Yang Department of Cardiology, Ankang Central Hospital, Ankang 725000, China  
ZHOU Kun Department of Cardiology, Ankang Central Hospital, Ankang 725000, China xuesn00@163.com 
MA Xiang Heart Center, First Affiliated Hospital of Xinjiang Medical University, Urumqi 830054, China  
Hits: 58
Download times: 130
Abstract:
      Objective To investigate the molecular mechanism of mitochondrial mitochondrial ATP-sensitive potassium channels (mitoKATP) opener in improving myocardial oxidative stress/injury in rates with coronary heart disease (CHD). Methods A total of 40 SD rats were randomly divided into 4 groups with 10 in each:control group (without modeling and intervention of diazoxide drug), sham operation group (with skin cutting but without modeling), and model group (modeling of coronary heart disease but without intervention of diazoxide) and drug group (with modeling of coronary heart disease and intervention of diazoxide at 3 mg/kg). mRNA expression of angiogenic factors[fibroblast growth factor 2 (FGF-2) and vascular endothelial growth factor (VEGF)] and related proteins for each group were measured using real-time fluorescence quantitative polymerase chain reaction and Western blotting. The groups were compared in lactate dehydrogenase, mitochondrial membrane potential (MMP) and cell death rate. SPSS statistics 22.0 was used of data processing, and analysis of variance (ANOVA) or t test for comparison between groups. Results Compared with the model group, drug group had significantly lower mRNA transcription of FGF-2 [(100.21±12.33)×103 vs (120.43±10.33)×103 IU] and VEGF [(163.31±9.33)×103 vs (181.33±11.13)×103 IU] and expression of FGF-2 [(0.69±0.33) vs (1.32±0.33)], VEGF [(0.68±0.33) vs (1.20±0.13)], and lactate dehydrogenase [(49.32±3.51) vs (156.12±10.18)U/L]. Compared with the model group, the cell death rate in the drug group decreased [(30.32±3.48)% vs (66.12±3.23)%], but the fluorescence intensity increased [(780.12±9.20) vs (220.24 ±6.15)] (P<0.05). Conclusion mitoKATP channel opener can decrease MMP, cell death rate and myocardial oxidative stress/injury in rats with coronary heart disease by increasing vascular FGF-2 and VEGF and enhancing activity of lactate dehydrogenase.
Close